Genetic and metabolic hallmarks of clear cell renal cell carcinoma

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Clear cell renal cell carcinoma (ccRCC) exhibits dysregulated hypoxia-inducible factor signaling, chromatin modifier mutations, and metabolic alterations.
• Traditional ccRCC preclinical studies relied on cell cultures, limiting translational relevance.
• Recent advances include genetically engineered mouse models (GEMMs) that mimic ccRCC phenotypes.

Purpose of the Study:

• To review recent literature on ccRCC pathogenesis and preclinical models.
• To discuss the implications of new findings for targeted ccRCC therapies.
• To highlight the utility of GEMMs in understanding ccRCC.

Main Methods:

• Literature review of recent studies on ccRCC.
• Analysis of findings from large-scale patient sequencing data.
• Examination of genetically engineered mouse models of ccRCC.

Main Results:

• Identification of critical tumor suppressors and oncogenes in ccRCC.
• Development of GEMMs that recapitulate key ccRCC features.
• Emerging understanding of ccRCC's complex molecular underpinnings.

Conclusions:

• GEMMs offer improved preclinical platforms for ccRCC research.
• Understanding molecular alterations informs the development of targeted ccRCC treatments.
• Continued research in this area is vital for advancing ccRCC therapy.